Itch, burns, jeuk, brandwonden
Conditions
Interventions
Patients will be randomized to start with either the doxepin cream or the placebo cream. Patients will be required to use the cream at least once daily for two consecutive weeks. This is followed by a
Sponsors
Prof. E. Middelkoop, PhD
Association of Dutch Burn Centres
Zeestraat 27-29, 1941 AJ Beverwijk
Eligibility
Inclusion criteria
Inclusion criteria: - Age ≥ 18 years - Healed burns - Itch with an intensity ≥ 3 as determined by the VAS score for itch at time of the enrolment - Treatment in one of the three Dutch burn centres - Total area that itches must not exceed >10% TBSA
Exclusion criteria
Exclusion criteria: - Unable to give informed consent - Unable to understand and fill in VAS scores and questionnaires (as determined by the treating burn physician) - Cutaneous or systemic disease causing itch - Any diseases or condition that is associated with adverse effects using doxepin, that is: Hypersensitivity to any of its components, Glaucoma, A tendency to urinary retention, Sever liver disease, Mania, Sever heart disease (including cardiac arrhythmias), Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the change in pruritus intensity as measured by the Visual Analogue Scale (VAS), with a decrease of ≥2 point being defined as clinically significant. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary study parameters include the determination of the MIC of the itch scores, the characteristics and impact of itch as measured by the BIQ, and scar quality as measured by the POSAS. Other study parameters include: the use of hydrating cream, use of escape medication and use of pressure garments. Furthermore, we will register sex, age, medical history, cause of burn, location of burn wound, %TBSA burned, time to wound healing (will be estimated retrospectively), % burn wound area that itches, duration of itch, itch before inclusion and wound treatment (conservative or surgery). | — |
Contacts
Public ContactKelly Kwa
Outcome results
None listed